We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.1B
AUM Growth
+$2.24B
Cap. Flow
-$849M
Cap. Flow %
-1.97%
Top 10 Hldgs %
11.85%
Holding
2,563
New
364
Increased
1,030
Reduced
917
Closed
227

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$245M
2
META icon
Meta Platforms (Facebook)
META
+$204M
3
EXC icon
Exelon
EXC
+$196M
4
SHW icon
Sherwin-Williams
SHW
+$182M
5
PFE icon
Pfizer
PFE
+$174M

Sector Composition

Rank Sector Weight
1 Technology 16.65%
2 Healthcare 16.47%
3 Consumer Discretionary 15.27%
4 Industrials 11.92%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRC icon
2026
Tejon Ranch
TRC
$476M
$336K ﹤0.01%
+21,000
New +$343K
CRNT icon
2027
Ceragon Networks
CRNT
$194M
$335K ﹤0.01%
159,300
-84,700
-35% -$190K
CARE icon
2028
Carter Bankshares
CARE
$756M
$334K ﹤0.01%
+14,100
New +$292K
MIC
2029
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$334K ﹤0.01%
+7,800
New +$322K
SMBK icon
2030
SmartFinancial
SMBK
$855M
$333K ﹤0.01%
14,100
+4,400
+45% +$96.8K
GLAD icon
2031
Gladstone Capital
GLAD
$425M
$332K ﹤0.01%
16,738
-41,050
-71% -$826K
LUMO
2032
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$332K ﹤0.01%
14,578
-44
-0.3% -$628
HRTX icon
2033
Heron Therapeutics
HRTX
$86.3M
$331K ﹤0.01%
+14,100
New +$312K
VRSK icon
2034
Verisk Analytics
VRSK
$26.4B
$331K ﹤0.01%
2,219
-5,200
-70% -$770K
REGI
2035
DELISTED
Renewable Energy Group, Inc.
REGI
$331K ﹤0.01%
+12,300
New +$223K
NGNE icon
2036
Neurogene
NGNE
$696M
$330K ﹤0.01%
1,340
-580
-30% -$57.8K
NIU
2037
Niu Technologies
NIU
$202M
$330K ﹤0.01%
+38,700
New +$346K
QUAD icon
2038
Quad
QUAD
$430M
$330K ﹤0.01%
70,700
+56,400
+394% +$352K
AIFU
2039
AIFU Inc
AIFU
$201M
$330K ﹤0.01%
32
-26
-45% -$268K
GNK icon
2040
Genco Shipping & Trading
GNK
$1.17B
$329K ﹤0.01%
+31,000
New +$319K
RLH
2041
DELISTED
Red Lions Hotel Corporation
RLH
$327K ﹤0.01%
+87,700
New +$409K
EGBN icon
2042
Eagle Bancorp
EGBN
$867M
$326K ﹤0.01%
+6,700
New +$303K
FONR
2043
DELISTED
Fonar
FONR
$325K ﹤0.01%
16,500
-4,800
-23% -$96.2K
NHTC icon
2044
Natural Health Trends
NHTC
$15.4M
$324K ﹤0.01%
60,300
-26,900
-31% -$172K
CVEO icon
2045
Civeo
CVEO
$379M
$323K ﹤0.01%
20,864
-75
-0.4% -$940
GPX
2046
DELISTED
GP Strategies Corp.
GPX
$319K ﹤0.01%
24,100
+3,400
+16% +$42.2K
FRO icon
2047
Frontline
FRO
$8.75B
$317K ﹤0.01%
+24,620
New +$268K
BKD icon
2048
Brookdale Senior Living
BKD
$3.62B
$316K ﹤0.01%
+43,400
New +$322K
ICHR icon
2049
Ichor Holdings
ICHR
$3.02B
$316K ﹤0.01%
+9,500
New +$283K
GBL
2050
DELISTED
GAMCO Investors, Inc.
GBL
$316K ﹤0.01%
16,217
+300
+2% +$5.29K

Similar funds

Two Sigma Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Two Sigma Advisers held 2,563 positions worth $43.1B, up 5.5% from $40.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Two Sigma Advisers's Q4 2019 filing shows 364 new, 1,030 increased, 917 reduced and 227 closed positions. Its largest new stake was Netflix: 5,465,000 shares worth $177M. The largest sale was Microsoft, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Two Sigma Advisers's largest Q4 2019 buy was Netflix: 5,465,000 shares worth $177M.
  • Two Sigma Advisers added most to Merck in Q4 2019, an estimated $245M increase.
  • Two Sigma Advisers's biggest Q4 2019 reduction was Microsoft, cutting an estimated $400M.
  • Two Sigma Advisers fully exited Fidelity National Information Services in Q4 2019, selling an estimated $280M.
  • Two Sigma Advisers's ten largest holdings make up 12% of its $43.1B portfolio in Q4 2019.
  • Two Sigma Advisers opened 364 new positions and closed 227 in Q4 2019.
  • Two Sigma Advisers's portfolio value rose 5.5% quarter-over-quarter to $43.1B.

Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.